相关实验视频

Updated: Jun 20, 2025

Generation of Human Chimeric Antigen Receptor Regulatory T Cells

Generation of Human Chimeric Antigen Receptor Regulatory T Cells

Published on: January 3, 2025

对基因组编辑T细胞疗法的监管考虑

Julie K Jadlowsky¹, Ju-Fang Chang^2,3, David H Spencer³

¹Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania.

Cancer immunology research

|July 17, 2024

概括

像CRISPR这样的基因编辑技术正在彻底改变精准医学的细胞疗法. 将基因疗法与基因组编辑相结合,提高了疗效,并为先进的治疗应用引入了新的功能.

科学领域:

生物技术是生物技术.
基因组学就是基因组学.
细胞疗法细胞疗法

背景情况:

化学抗原受体 (CAR) 工程T淋巴细胞代表了一种开创性的细胞治疗方法.
经典的基因治疗载体最初用于将CAR转基因插入T细胞基因组.
基因组工程的进步正在推动治疗干预措施的创新.

研究的目的:

审查目前基因编辑细胞产品的现状.
讨论将基因疗法和基因组编辑整合到细胞疗法中.
检查这些先进疗法的科学,翻译和监管监督.

主要方法:

关于基因治疗和基因组编辑的科学文献的综述.
对工程细胞产品转化进展的分析.
检查管理基因编辑细胞疗法的监管框架.

主要成果:

基于克里斯普尔 (clustered regularly interspaced short palindromic repeats) 的技术,可以精确编辑内源基因.
基因治疗与基因组编辑的整合是开发新型细胞疗法的日益增长的趋势.
增强的治疗疗效和新的生物功能是综合方法的关键结果.

结论:

基因编辑细胞产品代表了精准医学的新时代.
基因治疗和基因组编辑的融合提供了重要的治疗潜力.
强有力的科学,翻译和监管监督对于这些技术的进步至关重要.

更多相关视频

Using CRISPR/Cas9 to Knock Out GM-CSF in CAR-T Cells

Using CRISPR/Cas9 to Knock Out GM-CSF in CAR-T Cells

Published on: July 22, 2019

Production of Human CRISPR-Engineered CAR-T Cells

Production of Human CRISPR-Engineered CAR-T Cells

Published on: March 15, 2021

相关概念视频

What is Genetic Engineering?

What is Genetic Engineering?

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...